1. Johnson & Johnson (online 14 February 2005) Stories of survival and hope mark the one million patient milestone for the CYPHER® sirolimus-eluting coronary stent (February 14, 2005). [
http://www.jnj.com/news/jnj_news/20050214_094141.htm
] (accessed 15 September 2005)
2. Boston Scientific (online 19 January 2005) Boston Scientific announces implantation of millionth TAXUS® Express coronary stent system [
http://www.bostonscientific.com/common_templates/articleDisplayTemplate.jsp?task=tskPressRelease.jsp§ionId=2&relId=24,25&uniqueId=ABPR5502
] (accessed September 15 2005)
3. van der Giessen WJ et al. (1996) Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94: 1690–1697
4. Morice MC (2005) A Prospective, Randomized, Multi-Center Comparison Study of the CYPHER® Sirolimus-Eluting and TAXUS™ Paclitaxel-Eluting Stent Systems. American College of Cardiology 54th Annual Scientific Sessions: 2005 March 6–9; Orlando
5. Sousa JE et al. (2001) Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103: 192–195